Activist hedge fund Parvus Asset Management is building a stake in Novo Nordisk , after the company lost its first mover ...

FILE PHOTO: A person walks near the Milan Bourse (Italian stock exchange) as global markets brace for a hit to trade and ...

Activist hedge fund Parvus Asset Management is building a stake in Ozempic-maker Novo Nordisk as the drugmaker hunts for a ...

A media report stated that an activist investor is accumulating a stake in the Wegovy maker. Wegovy and Ozempic maker Novo ...

This update covers current health news, focusing on Parvus Asset Management's influence on Novo Nordisk's CEO selection, ...

The current health news highlights a series of dynamic events, including Parvus Asset Management's stake in Novo Nordisk, WHO ...

Ryanair Holdings ( ($RYAAY) ) has issued an announcement. On June 2, 2025, Ryanair Holdings Plc was notified of a significant change in the ...

Parvus Asset Management, a London-based activist hedge fund, is acquiring a stake in Danish pharmaceutical company Novo Nordisk (NYSE: NVO), according to The Fina ...

AbbVie and Parvus Therapeutics have entered into an exclusive global license collaboration to develop and commercialise novel therapies to treat inflammatory bowel disease (IBD). As part of the deal, ...